AHR and asthma: Collectively, these results indicate an underlying mechanism for the anti-inflammatory role of α7nAChR agonist in asthma: modulating GATA-3 expression and proliferation in ILC2s, which subsequently attenuates Th2 cytokine production from ILC2s, preventing the development of AHR and allergic inflammation.